Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mesenchymal stem cells for the treatment of CNS diseases

Mesenchymal stem cells for the treatment of CNS diseases

US Patent 11185572 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and system for roads' maintenance2024
Vesicles comprising a PTEN inhibitor and uses of same2023
Mesenchymal cell-derived exosomes to treat neurological disorders2021
PERK inhibitors and uses thereof in treating diseases associated with aggregatio2021
Isolated cells and populations comprising same for the treatment of CNS diseases2020
Isolated cells and populations comprising same for the treatment of CNS diseases2020
Isolated cells and populations comprising same for the treatment of CNS diseases2020
Genetically modified muscle cells which express neurotrophic factors2020
Genetically modified muscle cells which express neurotrophic factors2020
Perk inhibitors and uses thereof in treating diseases associated with aggregatio2020
Combination treatment for amyotrophic lateral sclerosis (ALS)2019
Mesenchymal stem cells for the treatment of CNS diseases2018